Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
US10532089B2 · kind B2 · utility
2Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 12, 2016 |
| Grant date | Jan 14, 2020 |
| Priority date | — |
| Expiry date | Dec 20, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B20/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Contemplated cancer treatments comprise recursive analysis of patient-, cancer-, and location-specific neoepitopes from various biopsy sites of a patient after treatment or between successive rounds of immunotherapy and/or chemotherapy to inform further immunotherapy. Recursive analysis preferably includes various neoepitope attributes to so identify treatment relevant neoepitopes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.